Essa Pharma Inc Expected To Post A Loss Of 17 Cents A Share: Earnings Preview

ESSA Pharma

09/05/2025 16:42

ESSA Pharma Inc EPIX.OQ EPIX.O is expected to report results on August 4 (estimated) for the period ending June 30 2025

​LSEG's mean analyst estimate for ESSA Pharma Inc is for a loss of 17 cents per share.

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts had fallen by about 65.2% in the last three months. ​

Wall Street's median 12-month price target for ESSA Pharma Inc is $1.70​, below​ its last closing price of $1.71. ​​​

This summary was machine generated May 9 at 15:42 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)